Valuation : Boston Scientific Corporation

Market Cap 67.88B 58.45B 54.88B 50.1B 94.11B 6,459B 94.78B 650B 253B 3,275B 255B 249B 10,845B P/E 2026 *
17.5x
P/E 2027 * 18.5x
Enterprise Value 76.6B 65.95B 61.93B 56.53B 106B 7,288B 107B 734B 286B 3,696B 288B 281B 12,237B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.28x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day+2.89%
1 week-1.36%
Current month+3.46%
1 month+3.46%
3 months+0.76%
6 months-34.54%
Current year-49.30%
1 week 46.09
Extreme 46.09
50.04
1 month 46.09
Extreme 46.09
52.99
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 A Buy

Director

2,040 0.0001%
8/11/26 A Other

Controller/Auditor

2,930 0.0002%
8/10/26 A Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+2.90%-1.36%-54.67%-10.37% 67.88B
-0.48%-1.44%+27.11%+11.23% 230B
-0.88%-0.28%+5.26%-19.06% 152B
+1.06%+0.53%-19.94%+20.11% 132B
+0.58%+0.39%+11.10%+18.80% 52B
-0.99%-3.12%-17.97%-15.39% 51.05B
+0.10%+0.24%+22.84%+27.04% 43.38B
-0.18%+0.71%+39.52%+47.31% 40.74B
-0.33%+3.12%-11.54%+50.20% 34.67B
-0.78%-4.67%+117.53%+28.79% 32.55B
Average +0.19%-1.25%+11.92%+15.87% 83.58B
Weighted average by Cap. +0.13%-1.47%+7.64%+9.10%

Financials

2026 *2027 *
Net sales 21.37B 18.4B 17.27B 15.77B 29.62B 2,033B 29.83B 205B 79.64B 1,031B 80.22B 78.48B 3,413B 22.33B 19.23B 18.05B 16.48B 30.96B 2,125B 31.18B 214B 83.23B 1,077B 83.84B 82.02B 3,567B
Net income 3.84B 3.31B 3.1B 2.83B 5.32B 365B 5.36B 36.78B 14.31B 185B 14.41B 14.1B 613B 3.69B 3.17B 2.98B 2.72B 5.11B 351B 5.15B 35.31B 13.74B 178B 13.84B 13.54B 589B
Net Debt 8.72B 7.51B 7.05B 6.43B 12.09B 829B 12.17B 83.51B 32.49B 421B 32.73B 32.02B 1,393B 5.45B 4.69B 4.41B 4.02B 7.56B 519B 7.61B 52.23B 20.32B 263B 20.47B 20.02B 871B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
31/08/26 $48.26 +3.03% 11,589,722
28/08/26 $46.84 +0.36% 17,148,785
27/08/26 $46.67 -3.11% 16,277,169
26/08/26 $48.17 -3.39% 36,584,800
25/08/26 $49.86 +1.73% 17,368,920
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
46.84USD
Average target price
62.69USD
Spread / Average Target
+33.84%

Quarterly revenue - Rate of surprise